Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2014.07.011
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2015
Authors
Publisher
Elsevier BV